# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-029836
Filing Date
2022-11-14
Accepted
2022-11-14 16:15:13
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vyne-20220930.htm iXBRL | 10-Q | 1050337
2 | EX-3.1(B) | vyne-31bcertificateofdesig.htm | EX-3.1(B) | 143630
3 | EX-3.2 | vyne-32arbylaws.htm | EX-3.2 | 194465
4 | EX-10.1 | vyne-101spa.htm | EX-10.1 | 236478
5 | EX-10.2 | vyne-102rra.htm | EX-10.2 | 150892
6 | EX-31.1 | vyne-20220930xexx311.htm | EX-31.1 | 9711
7 | EX-31.2 | vyne-20220930xexx312.htm | EX-31.2 | 9705
8 | EX-32.1 | vyne-20220930xexx321.htm | EX-32.1 | 5289
9 | EX-32.2 | vyne-20220930xexx322.htm | EX-32.2 | 5280
| Complete submission text file | 0001628280-22-029836.txt |  | 5656944

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vyne-20220930.xsd | EX-101.SCH | 31740
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vyne-20220930_cal.xml | EX-101.CAL | 53481
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vyne-20220930_def.xml | EX-101.DEF | 207718
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vyne-20220930_lab.xml | EX-101.LAB | 438994
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vyne-20220930_pre.xml | EX-101.PRE | 293040
49 | EXTRACTED XBRL INSTANCE DOCUMENT | vyne-20220930_htm.xml | XML | 656017

Mailing Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 221385538
SIC: 2834 Pharmaceutical Preparations